Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Web Exclusives
HOPA Corner
,
Immunotherapy
Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy
Read More
HOPA Corner
DLL3-Targeting BiTE Therapy in SCLC: A Pharmacist’s Guide to Evidence and Integration
Read More
HOPA Corner
Checkpoint Inhibitors: Changing Colorectal Cancer Treatment
Read More
HOPA Corner
505(b)(2) Drugs: New Chaos for Infusion Centers
Read More
HOPA Corner
,
Disparities in Oncology Care
The Crossroad of Social Determinants of Health and Inequalities in Hematologic Malignancies
By Cara Guglielmon
Read More
HOPA Corner
Embracing Equity: The Evolving Role of HOPA in Advancing Fairness, Access, and Representation
Read More
Immunotherapy
HARMONI-2 Demonstrating “Significant” Improvement in PFS With Ivonescimab Over Pembrolizumab
Read More
Lymphoma
Group Aiming to Cure Follicular Lymphoma Awarded $2.25 Million
Read More
Perspective
Prescription Drug Provisions in the Inflation Reduction Act of 2022: A Payer Perspective
Read More
FDA Updates
FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management
Jerm Day-Storms, PhD, MWC
Read More
1
2
3
4
Page 1 of 43
Results 1 - 10 of 425
